MDMA
Synthesis Route
The dominant route is reductive amination of safrole (or its precursors PMK, MDP2P) with methylamine and a reducing agent (aluminum amalgam or sodium borohydride). Safrole derives from sassafras oil. Cartel-scale production now uses synthetic PMK precursors.
Predictable Synthesis Byproducts
- PMK — incomplete reduction leaves traces of starting material.
- MDA — the demethylated cousin of MDMA. Often present in trace amounts; sometimes deliberately enriched.
- Aluminum salts — when aluminum amalgam reduction is used.
- Solvent residues — toluene, methanol, hydrochloric acid.
Typical Adulterants
MDMA is one of the most adulterated drugs in the supply. The relevant probability is not just "what's mixed in" — it's whether it's even MDMA at all.
Baseline estimate: roughly a 1-in-2 chance a street "MDMA" sample is pure MDMA, and a meaningful chance it contains no MDMA whatsoever. (Palamar et al., 2024; EcstasyData/DanceSafe 2010–2024; data current as of 2024 — prevalence figures shift year-to-year)
| Adulterant | Est. probability | Why it matters |
|---|---|---|
Synthetic cathinones"bath salts" — methylone, ethylone, eutylone, pentylone, alpha-PVP |
Moderate–high | Most common MDMA adulterant class over the past decade (Brunt et al., 2017). Higher cardiovascular risk than MDMA; longer duration; can cause psychosis. Marquis reagent turns dark, falsely indicating MDMA. |
Caffeine |
Moderate | Masks weak content; cardiac stress at high doses |
Methamphetamine |
Low–moderate | Pure stimulant load, no empathogenic effect |
2C-B, 2C-Iphenethylamine psychedelics |
Low | Psychedelic, not empathogenic; higher dose-sensitivity |
DXMdissociative |
Low | Dissociative effects; serotonin syndrome risk with SSRIs |
PMA / PMMA"death amphetamine" |
Low | Slow onset (1–2 hrs) → user redoses → sudden hyperthermia and serotonin syndrome. Low probability, lethal outcome. |
Fentanyl |
Very low | Documented but rare in MDMA. Lethal in opioid-naive users. |
Removal & Testing
MDMA cannot be re-purified once cut. Synthetic cathinones are chemically similar enough that they cannot be separated without lab equipment.
Reagent testing is essential and accessible. Use reagents in series to identify adulteration:
| Reagent | MDMA result | Cathinone result | What it confirms |
|---|---|---|---|
| Marquis | Purple/black | Yellow/orange | Presence of MDMA class |
| Mecke | Blue-green | Brown/yellow | Distinguishes from cathinones |
| Mandelin | Black | Variable | Secondary confirmation |
| Simon's | Blue | No reaction | Confirms secondary amine (rules out MDA) |
A sample that turns dark on Marquis but yellow on Mecke is likely a cathinone, not MDMA. Use reagents in series — one kit is not enough.
Fentanyl test strips are recommended despite low fentanyl probability, because of consequence. Quantitative mail-in services (DrugsData/EcstasyData, Energy Control, DIMS) give actual mg content.
Sources: Full references for the citations in this submodule (Palamar et al., 2024; Brunt et al., 2017; Lambdin et al., 2023; EcstasyData/DanceSafe, 2010–2024) are listed in the Module 10 Sources section.